The University of Chicago Header Logo

Connection

Michael Becker to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Clinical Trials, Phase II as Topic.
Michael Becker
Connection Strength
0.020
Clinical Trials, Phase II as Topic
  1. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology (Oxford). 2009 Feb; 48(2):188-94.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.